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REVIEW
Abstract: With the looming expansion of the elderly population of the US, a thorough
understanding of “normal” aging-related changes on the respiratory system is paramount.
The respiratory system undergoes various anatomical, physiological and immunological
changes with age. The structural changes include chest wall and thoracic spine deformities
which impairs the total respiratory system compliance leading to increase work of breathing.
The lung parenchyma loses its supporting structure causing dilation of air spaces: “senile
emphysema”. Respiratory muscle strength decreases with age and can impair effective cough,
which is important for airway clearance. The lung matures by age 20–25 years, and thereafter
aging is associated with progressive decline in lung function. The alveolar dead space increases
with age, affecting arterial oxygen without impairing the carbon dioxide elimination. The
airways receptors undergo functional changes with age and are less likely to respond to drugs
used in younger counterparts to treat the same disorders. Older adults have decreased sensation
of dyspnea and diminished ventilatory response to hypoxia and hypercapnia, making them
more vulnerable to ventilatory failure during high demand states (ie, heart failure, pneumonia,
etc) and possible poor outcomes.
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Introduction
Since the 1950s the median age of the US population increased by 20 years. Increased
life expectancy reflects, in part, a better understanding of the disease states, newer
interventions, and the success of public health programs. The number of persons
aged 65 and over is projected to increase from 35 million in 2000 to an estimated 71
million in 2030, with the largest increase in individuals age 80 and above (US Census
2005). Differentiating a disease state from “normal” aging is vital when encountering
this population in the clinical setting. Respiratory system undergoes various structural,
physiological, and immunological changes with age. There is a large variation in
different physiologic measures among older adults, making it difficult to construct
“normal” limits to differentiate a disease from a normal state. The current review
explores age-related structural, physiological, and immunological changes of the
respiratory system. These changes may in part explain older individuals’ clinical
presentation and/or aberrant diagnostic studies, avoiding unnecessary interventions,
and how these changes may predispose these vulnerable individuals to increased
risk for respiratory diseases. Moreover, these changes may in part be responsible for
variable response to currently available drugs to treat pulmonary diseases in older
adults.
Respiratory system mechanics
The respiratory system comprises primarily the thoracic cage, lungs, and diaphragm.
Total respiratory system compliance includes lung and chest wall compliance.
Compliance is change in volume relative to change in pressure. Lung compliance
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determines the rate and force of expiration and the thoracic
compliance determines the elastic load during inspiration.
With aging there are structural changes to the thoracic cage
causing reduction in chest wall compliance. Age-related
osteoporosis results in reduced height of the thoracic
vertebrae. Stiffening of the thoracic cage from calcification
of the rib cage and age-related kyphosis from osteoporosis
reduces the ability of the thoracic cage to expand during
inspiration and places the diaphragm at a mechanical
disadvantage to generate effective contraction. Mittman et
al (1965) studied total respiratory compliance in 42 healthy
male subjects, ages 24 to 78 yrs, with 5 subjects being age
≥70 years. Lung compliance was similar, but the chest wall
compliance was lower in older subjects. Moreover, subjects
with lower chest wall compliance had higher residual
volume (RV), suggesting an impediment to complete
emptying of the lungs from stiff chest wall (Mittman et al
1965).
Respiratory muscle function
The diaphragm is the most important respiratory muscle and
plays an essential role during inspiration. Exact
measurement of diaphragmatic strength can only be done
in vivo. There is very little information on the effect of aging
on the contractile properties of the diaphragm. Respiratory
muscle strength can be measured by transdiaphragmatic
pressure (Pdi), maximum voluntary ventilation (MVV), and
maximum inspiratory pressure (MIP). MIP is an index of
strength of the diaphragm measured using a mechanical
pressure gauge with a closed valve at the mouth during an
inspiration. MIP is an indicator of inspiratory muscle
strength and a determinant of vital capacity. Decline in MIP
can lead to inadequate ventilation and impaired clearance
of airway secretions, as seen in patients with neuromuscular
disease. Studies measuring MIP have been cross-sectional,
and their primary objective has been to establish reference
values rather than to evaluate the longitudinal impact of
age on diaphragmatic function. MIP is 30% higher in men
compared with women at all age groups and decreases by
0.8 cm to 2.7 cm of H20/year between the ages of 65 and 85
years, with larger age-related declines seen in men (Enright
et al 1994). Tolep et al (1995) showed a 25% lower Pdi
measured using Mueller maneuver in healthy older subjects
(age 65–75, n=10) compared with young healthy adults (age
19–28, n=9). Similar results were seen in a study by Polkey
et al (1997). The degree of reduction in Pdi in healthy older
compared with healthy young controls was less (13%) in
the latter study, partly explained by different measurement
techniques (Table 1). Maximum voluntary ventilation is also
reduced with age, and one longitudinal study showed a 12%
decline over 6 years in older trained athletes (McClaran et
al 1995). Likely explanation for reduced diaphragmatic
strength with age is related to muscle atrophy and age-related
decrease in fast twitch fibers, responsible for generating
higher peak tensions. This age-related decline in
diaphragmatic strength may predispose older individuals to
diaphragmatic fatigue and ventilatory failure during
increased ventilatory load on the respiratory system.
Anatomical changes
Senile hyperinflation of the lungs is a well known entity in
the medical literature. It is not clear whether it reflects aging-
associated destruction of lung parenchyma or loss of
supporting structures within the lung parenchyma. Gillooly
and Lamb (1993) studied 38 (age ≥65 yrs, n=14) autopsy
or surgical lung resection specimens in lifelong nonsmokers
and showed increase in airspace size with advancing age.
There is homogeneous degeneration of the elastic fibers
around the alveolar duct starting around 50 years of age
resulting in enlargement of airspaces. Reduction in
supporting tissue results in premature closure of small
airways during normal breathing and can potentially cause
air trapping and hyperinflation, hence “senile emphysema”.
Immunologic changes
Bronchoalveolar lavage (BAL) fluids in healthy older
subjects have consistently shown an increased proportion
of neutrophils and lower percentage of macrophages
compared with younger adults. There is age-associated
increase in immunoglobins IgA and IgM in the BAL fluid.
Ratio of CD4+/CD8+ lymphocyte increases with age in the
BAL fluid, suggesting the presence of primed T-cell from
repeated antigenic stimuli of the lower respiratory tract
mucosa (Meyer et al 1996). Moreover, there is increased
ability of alveolar macrophages to release superoxide anion
Table 1 Aging and respiratory muscle strength
Study Technique Pdi (cm Reduction p-value
of H20)
Young Elderly
Tolep et Mueller 171±8 128±9 25% <0.003
al 1995
Polkey et Sniff 136±17 119±22 13% 0.05
al 1997
Abbreviations: Pdi, transdiaphragmatic pressure.Clinical Interventions in Aging 2006:1(3) 255
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in response to stimuli in the elderly. These changes likely
represent the combined affect of repetitive antigenic stimuli
from environmental exposure and age-related decline in
down regulatory response to antigenic exposure. Persistent
low grade inflammation in the lower respiratory tract can
cause proteolytic and oxidant-mediated injury to the lung
matrix resulting in loss of alveolar unit and impaired gas
exchange across the alveolar membrane seen with aging.
The clinical implication of immune dysregulation with age
is yet to be determined.
The cellular profile of epithelial lining fluid (ELF)
changes with age. The ELF is rich in antioxidant defenses
and minimizes oxidative injury to the respiratory epithelium
following toxic exposure. ELF is rich in superoxide
dismutase, catalase, metal binding proteins, glutathione, and
vitamins C and E. In vitro and in vivo studies showed
reduction in antioxidant levels in the ELF on exposure to
ozone, nitrous oxide, and particulate matter. Composition
of ELF changes with age, increasing susceptibility of older
individuals to environmental toxic exposure (Kelly et al
2003) (Figure 1).
Lung function
Lung function can be divided into three categories:
spirometry to assess the dynamic flow rates: forced
expiratory volume in one second (FEV1), forced vital
capacity (FVC), and FEV-1/FVC ratio. The dynamic flow
rates are dependant on lung volumes (Table 2). The static
lung volumes include total lung capacity (TLC), vital
capacity (VC), residual volume (RV), and functional residual
capacity (FRC) (Figure 3). The gas exchange across alveolar
capillary membrane is measured using diffusion capacity
for carbon monoxide (DLCO). Pulmonary function tests are
reported as % predicted compared with individuals of same
age, sex, and height.
The lungs undergo a phase of growth and maturation
during the first two decades of life and achieve maximal
lung function around age 20 years in females and 25 years
in males. Lung function remains steady with very minimal
change from age 20 to 35 years and starts declining thereafter
(Figure 3). The decline in pulmonary function tests depends
on peak lung function achieved during adulthood, the
duration of the plateau phase, and rate of lung function
decline. Studies on lung function are done either to establish
the reference values for the pulmonary function laboratories
or to determine the age-related decline (Knudson 1981;
Janssens et al 1999; Zeleznik 2003).
The variability in similar physiologic measurements is
much greater among healthy older individuals compared
with younger individuals, making it problematical to
establish a “normal” range for the older adults. Most
prediction equations are derived from cross-sectional studies
with under representation from older adults and ethnic
minorities. The cohort and period effect unique to the cross
sectional studies can under- or overestimate the lung
function. Environmental exposures, nutritional deficiencies,
or childhood infection common to individuals born within
Figure 1 Effect of environmental exposure on airways.
Air space dilatation and
impaired gas exchange
Damage lung
matrix 
Environmental 
toxin 
ŃCD4+/CD8  Ĺ Neutrophils Release of 
 superoxide 
Table 2 Static lung volumes
Tidal volume (TV) Volume of air inspired or expired
during quiet breathing
Inspiratory reserve volume (IRV) Maximum volume of air inspired
above the tidal volume
Expiratory reserve volume (ERV) Maximum volume of air expired
below the tidal volume
Residual volume (RV) Amount of air in the lungs after
maximum expirationClinical Interventions in Aging 2006:1(3) 256
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a defined time period that may not be present in successive
generations explains why younger individuals now have a
higher lung function compared with 50 years ago. The
cumulative cohort effect is estimated to be 5 ml/yr. This
means that each former 25 year old generation had a vital
capacity which is lower by 125 ml compared with the present
generation (Xu et al 1995).
On the contrary, period effects include changes in
techniques, equipment, and “learning effect” from
repeated measures that can all improve the lung function
measurement on subsequent studies. Studies estimating
the period effect on lung function showed an average
FEV1 increase by 250 ml in men and 219 ml in women
during two different survey periods (from 1973–1978 and
1985–1990) (Xu et al 1995). Most cross-sectional studies
showed linear decline in FEV1 with age and,
underestimated the rate of decline. Longitudinal studies
showed a nonlinear decline with age. The estimated rate
of decline in FEV1 is 25–30 ml/yr starting at age 35–40
years and can double to 60ml/yr after age 70 years.
Precise rate of decline is difficult to assess as inter-
individual variability (up to 125 ml) far surpasses the
estimated annual decline by various regression equations
(Morris et al 1971; Crapo et al 1981; Knudson et al 1983;
Dockery et al 1985; Burrows et al 1986; Ware et al 1990;
Roberts et al 1991; Enright et al 1993; Kerstjens et al
1997) (Table 4).
Lung volumes depend on body size, especially height.
Total lung capacity (TLC) corrected for age remains
unchanged throughout life. Functional residual capacity and
residual volume increase with age, resulting in a lower vital
capacity.
Gas exchange in the lungs occurs across the alveolar
capillary membrane. It is measured by diffusing capacity of
carbon monoxide (DLCO). The DLCO is dependant upon
Figure 3 Age-related decline in forced expiratory volume in one second (FEV1)% predicted plotted as % of maximal at age 20 years against age.
Note: Adapted from Ware JH, Dockery DW, Louis TA, et al. 1990. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults.
Am J Epidemiol, 132:685-700. Copyright © 2004. Reprinted with permission from Oxford University Press.
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Figure 2 Relationship between lung volumes and lung capacities.
Abbreviations: ERV, expiratory reserve volume; FRC, functional residual
capacity; IC, inspiratory capacity; IRV, inspiratory reserve volume; RV, residual
volume; TLC, total lung capacity; TV, total volume; VC, vital capacity.
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lung volume (TLC) and alveolar ventilation. Diffusion
across the alveolar–capillary interface is directly
proportional to the alveolar surface and inversely
proportional to the alveolar–capillary membrane thickness.
Stam et al (1994) studied effect of age on diffusion capacity
in 55 healthy subjects (age ≥70 yrs, n=3) and showed a
decline in DLCO with age corrected for alveolar volume.
This suggests alteration in the alveolar–capillary membrane
as the potential mechanism, though not proven.
Dyspnea and response to hypoxia
and hypercapnia
Minute ventilation, a product of volume inhaled per breath
and respiratory rate over one minute, is identical in younger
and older individuals. There is no change in tidal volume
with age, and older individuals maintain the required minute
ventilation by increasing the respiratory rate. The ventilatory
response to lower oxygen tension or raised carbon dioxide
tension is markedly impaired in older adults. Kronenberg
and Drage (1973) studied 8 healthy young and 8 older
subjects and noted a 50% reduction in response to hypoxia
and 40% reduction in response to hypercarbia. These results
were confirmed by Peterson et al (1981) in a study of older
healthy adults. Aging is associated with loss of potentially
protective mechanisms and this patient population is more
likely to be exposed to these states, making them more
vulnerable. The likely explanation of reduced response is
age-related decline in efferent neural output to respiratory
muscles during hypoxic or hypercarbic states, supported by
the fact that older adults generate lower occlusion pressure
compared with younger individuals during these states
(Peterson et al 1981).
Bronchial hyper-responsiveness
and age-related pulmonary
receptor changes
Age had a significant effect on airway reactivity and
response to bronchodilator therapy. Airway reactivity is
studied using methacholine challenge in the pulmonary
function laboratory. Most individuals will experience
bronchospasm to inhaled methacholine, and the dose
required to cause significant reduction in FEV1 (ie, 20%
reduction from the baseline) determines the bronchial
reactivity. Lower doses signify increased bronchial reactivity
and higher likelihood of asthma. Hopp et al (1985)
retrospectively studied the cumulative methacholine dose
required to produce a 20% decline in FEV1 in 148 healthy
subjects (age ≥70, n=7) and showed a hyperbolic curve,
suggesting that younger and older individuals required lesser
methacholine doses to cause significant bronchoconstriction
compared with middle-aged individuals. Not only do older
individuals require a lower cumulative dose to cause
bronchoconstriction, they take longer to recover post β-
adrenergic agonist therapy (Connolly et al 1995). The exact
mechanisms of these findings are unclear. It is speculated
that this is likely due to age-related β-adrenergic receptor
dysfunction.
β β β β β-adrenoreceptor
β-adrenoreceptor stimulation by agonist or antagonist is
mediated through cyclic adenosine monophosphate (AMP)
production. Adenosine triphosphate (ATP) is converted to
cyclic AMP by catalytic unit of adenylate cyclase in the
presence of a ligand. The β-adrenoreceptor can exist in two
Table 3 Lung capacities are sum of two or more static lung
volumes
Inspiratory capacity (IC) TV + IRV
Functional residual capacity (FRC) RV + ERV
Vital capacity (VC) TV + IRV + ERV
Total lung capacity (TLC) TV + IRV + ERV + RV
Abbreviations: ERV, expiratory reserve volume; IRV, inspiratory reserve
volume; RV, residual volume; TV, tidal volume.
Table 4 Lung function studies
Study Time Cross-sectional (C)/ Age range N Age ≥ ≥ ≥ ≥ ≥65 years Decline
Longitudinal (L)
Morris et al 1969–70 C 20–84 988 79 Linear
Crapo et al 1979–80 C 18–91 251 68 Linear
Knudson et al 1972–75 C 6–88 421 - Linear
Dockery et al 1974–76 C 25–74 2454 430 Nonlinear
Burrows et al 1972–84 L 20–72 466 - Nonlinear
Ware et al 1974–83 L 25–74 2454 430 Nonlinear
Enright et al 1989–90 C 65–85 777 777 Linear
Note: Adapted from Kerstjens HAM, Rijcken B, Schouten JP, et al. 1997. Decline of FEV by age and smoking status: facts, figures, and fallacies. Thorax, 52:820-7.
Copyright © 1997. Reproduced with permission from BMJ.Clinical Interventions in Aging 2006:1(3) 258
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physiological states: high or low affinity. Cyclic AMP
production is reduced during agonist binding to a low affinity
state. The β-receptor density remains unchanged during
lifetime, but receptor affinity is reduced (Abrass and Scarface
1982). This reduction in high affinity receptor represents
functional uncoupling of the receptor from the adenyl cyclase
complex and impaired receptor-mediated adenyl cyclase
activity (Feldman et al 1984; Connolly 1993)  (Figure 4).
Muscarinic receptor
The data on age-related changes in pulmonary muscarinic
receptor in humans is limited. A study on age-related changes
in muscarinic receptors in guinea pigs showed no change in
the receptor density but noticed a significant reduction in
high affinity agonist binding sites in old tissues compared
with young tissues. There was a change in the muscuranic
receptor subtypes and receptor coupling to G proteins with
senescence (Willis-Karp 1993). Clinical significance of
these findings in terms of variation in anticholinergic
responsiveness in older adults is yet to be determined.
Cysteinyl-Leukotriene (CysLT1)
receptor
The stimulation of cysteinyl-leukotriene (CysLT1) receptor
located on the airway smooth muscles induces
bronchoconstriction. CysLT1 antagonists, namely zafrilukast
and montelukast, have shown promise in the treatment of
asthma in younger adults. There are no in vivo or in vitro
studies looking at the effect of age on CysLT1 receptors.
Nonetheless, clinical studies of leukotriene receptor
antagonist in the treatment of asthma showed minimal
improvement in FEV1 in older adults with asthma. Meta-
analysis of five randomized, double-blind studies of over
1900 patients showed treatment with zafrileukast in older
adults with asthma showed no improvement in lung
function; on the contrary, it increases asthma exacerbations.
The latter observation is of particular concern as older adults
have reduced perception of dyspnea which may cause delay
in getting medical attention (Cuttitta et al 2001). Baseline
airway reversibility was similar across all age groups, and
the lack of improvement in lung function are unlikely to be
explained by “fixed airway disease” secondary to airway
remodeling in older adults (Creticos et al 2002). Similar
results were noticed in an open label trial of over 3700
patients on zafrileukast (Korenblatt et al 2000).
In summary, the clinical significance of age-related β-
adrenoreceptor and muscuranic receptor changes are not
well studied, but the role of CysLT1 receptor antagonist in
older adults remains controversial.
Exercise capacity
The effect of aging on exercise capacity is highly variable
and depends upon individual fitness and regular physical
activity. Maximum oxygen consumption (VO2 max), an
objective surrogate of fitness, peaks between 20 to 30 years
of age, then declines by a rate of about 1% per year
depending upon individual level of physical activity
(declining more in sedentary compared with physically
active adults). McClaran et al (1995) studied the longitudinal
effects of aging on lung function at rest and during exercise
in healthy older adults and showed an 11% reduction in
VO2 max as a group over a 6 year period. All participants
were highly trained in aerobic fitness, and their VO2 max
was still twice the age predicted maximum. The ventilatory
Table 5  Ventilatory response to hypoxia and hypercapnia
Young Elderly p-value
(22–30 (64–79
years) years)
VE (Minute ventilation) in litres/min
Kronenberg et al 1973
PaO2 40 mm Hga 40.1±4.7 10.2±1.2 <0.001
PaCO2 (L/min/mm Hg)b 3.4±0.5 2.0±0.02 <0.025
Peterson et al 1981
SpO2 75%c 30.3±2.9 L/min 20.9±2.3 L/min <0.01
PaCO2 60 mm Hg
d 48.7±4.3 L/min 34.6±2.9 L/min
Note: 
aChange in minute ventilation from baseline to during hypoxia (arterial
oxygen tension of 40 mm of Hg); 
bChange in minute ventilation per unit change
in arterial carbondioxide tension from baseline; 
cminute ventilation at arterial
oxygen saturation of 75%; 
dminute ventilation at arterial carbondioxide tension
of 60 mm Hg.
   
 
ATP  cAMP
Phosphorylation 
ß-adrenoreceptor + 
Figure 4 Mechanism of action of beta agonist.
Abbreviations: ATP, adenosine triphosphate; cAMP, cyclic adenosine
monophosphate.Clinical Interventions in Aging 2006:1(3) 259
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response for a given CO2 production is higher in older adults
compared with younger individuals, suggesting a possible
increase in dead space ventilation (Vd/Vt) (Table 5). Tenney
and Miller (1956) studied 18 healthy males between the
ages of 68 and 89 years and showed that Vd/Vt is a
disproportionately large fraction of total minute ventilation
in older individuals (235±67.5 ml). Dead space ventilation
increases by 55% compared with that of younger adults
(average Vd/Vt in younger adults 150 ml). A 5 mm Hg
increase in A-a gradient raises dead space ventilation by
about 40 ml. Increase in Vd/Vt with age reflects disparity
in the distribution of ventilation and perfusion with age.
Additional age-related changes including reduced heart rate
response, cardiac output, and peripheral muscle mass may
account for the decline in VO2 max with age rather than
reduced lung function alone.
Summary
There is marked variation in the effect of aging on lung
function. Aging is associated with reduction in chest wall
compliance and increased air trapping. The decline in FEV1
with age likely has a nonlinear phase with acceleration in
rate of decline after age 70 years. There is an increase in
airspace size with aging resulting from loss of supporting
tissue. Respiratory muscle strength decreases with age and
much more so in men than in women (Table 6). Despite
these changes the respiratory system is capable of
maintaining adequate oxygenation and ventilation during
the entire life span. However, the respiratory system reserve
is limited with age, and diminished ventilatory response to
hypoxia and hypercapnia makes it more vulnerable to
ventilatory failure during high demand states (ie, heart
failure, pneumonia, etc) and possible poor outcomes.
Moreover, the reduced perception of bronchial constriction
may result in delayed medical attention. Sustained
inflammation of the lower respiratory tract may predispose
older adults to increased susceptibility to toxic
environmental exposure and accelerated lung function
decline. As Americans are getting older, future studies need
to address the clinical implication of “normal” age-related
changes of the respiratory system.
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